They mentioned providing monthly updates going through the pre-IDE process on their original LinkedIn post, see below.
Good morning.
Company CEO Mike Korenko is in the process of providing a market update as to where we're at in the Pre–Submission IDE process in regards to RadioGel™ - cancer therapy for Humans. The first one will be out before the end of summer. We will then begin providing general updates on a monthly basis (or sooner), if something substantially changes. Currently we're proceeding on the timeline we've previously established with the FDA.
In regards to IsoPet® - cancer therapy for Pets we're full steam ahead on regional clinic expansion; and shortly, we'll begin an Ad Campaign to further share the awareness of our product to Pet Parents and the #veterinarian community in general.